RSCM
EPIX

Rock Springs Capital Management’s ESSA Pharma EPIX Stock Holding History

Rock Springs Capital Management’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-677,005
Closed -$4.1M – 113
2024
Q3 		$4.1M Hold
677,005
– – 0.13% 87
2024
Q2 		$3.56M Hold
677,005
– – 0.11% 93
2024
Q1 		$5.75M Hold
677,005
– – 0.15% 90
2023
Q4 		$4.47M Hold
677,005
– – 0.11% 83
2023
Q3 		$2.09M Buy
677,005
+13,688
+2% +$39.4K 0.06% 99
2023
Q2 		$1.79M Buy
663,317
+138,373
+26% +$406K 0.04% 108
2023
Q1 		$1.56M Hold
524,944
– – 0.04% 108
2022
Q4 		$1.32M Hold
524,944
– – 0.03% 109
2022
Q3 		$955K Hold
524,944
– – 0.02% 121
2022
Q2 		$1.65M Hold
524,944
– – 0.05% 118
2022
Q1 		$3.24M Buy
524,944
+13,900
+3% +$122K 0.08% 119
2021
Q4 		$7.26M Buy
511,044
+3,000
+0.6% +$33.4K 0.17% 104
2021
Q3 		$4.06M Buy
508,044
+5,009
+1% +$79.6K 0.09% 132
2021
Q2 		$14.4M Hold
503,035
– – 0.28% 95
2021
Q1 		$14.6M Buy
+503,035
New +$11.7M 0.32% 86

Other funds holding EPIX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Rock Springs Capital Management's EPIX Position: Q4 2024 in Review

Rock Springs Capital Management sold out of ESSA Pharma (EPIX) in Q4 2024, closing a stake of 677,005 shares — an estimated $4.1M sold.

Rock Springs Capital Management first reported a position in EPIX in Q1 2021 and held it in 15 quarters. The position peaked at $14.6M in Q1 2021. 46 funds tracked by Wall St. Rank hold EPIX as of Q4 2024.

  • Rock Springs Capital Management reported no remaining ESSA Pharma position as of Q4 2024 after selling out during the quarter.
  • Rock Springs Capital Management sold 677,005 ESSA Pharma shares in Q4 2024, an estimated $4.1M.
  • Rock Springs Capital Management first reported a position in ESSA Pharma in Q1 2021 and held it in 15 quarters.
  • Rock Springs Capital Management's ESSA Pharma position peaked at $14.6M in Q1 2021.
  • 46 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2024.

Based on Rock Springs Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.